CRISPR Therapeutics: A New Era In Infectious Disease Management

(MENAFN- GlobeNewsWire - Nasdaq) CRISPR-based therapeutics present market opportunities in infectious diseases through genome disruption, host gene editing, and immune cell engineering. Key areas include innovative products, emerging companies, strategic partnerships, unmet needs, and future technological advances in the global pipeline.

Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "CRISPR Gene Editing in Infectious Diseases: Market Overview" report has been added to ResearchAndMarkets.com's offering.
The report provides an overview of the potential of CRISPR-based therapeutics in the infectious disease space.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a precision gene-editing tool that enables targeted modification of DNA. It uses a guide RNA to direct a CAS enzyme (such as Cas9 or Cas12) to a specific genetic sequence, where it creates a cut and allows for the insertion, deletion, or correction of DNA. In infectious diseases, CRISPR may be used to directly disrupt viral genomes, edit host susceptibility genes, or engineer immune cells to fight persistent pathogens.

Report Scope

• Overview of CRISPR gene editing, including history of development
• Assessment of unmet needs and challenges in the space (gap analysis)
• Profiles of key pipeline products and emerging companies
• Overview of major deals and acquisitions in the space between 2013 and 2025
• Insights into ethical considerations and future outlook

Reasons to Buy

• Develop an understanding of the potential of CRISPR-based therapeutics in the infectious disease space.
• Gain insights into the innovative products and technologies, and emerging companies with potential to shape the future market.
• Recognize gaps, challenges, and areas of unmet need within this space.
• Identify opportunities for consolidations, investments, and strategic partnerships.

Key Topics Covered:

• Executive summary
• CRISPR Gene Editing Overview
• Unmet Needs and Challenges
• Pipeline Products
• Clinical Trials
• Companies
• Deals
• Ethics
• Regulation
• Opportunities and Future Outlook

Company Coverage:

• Excision BioTherapeutics
• Locus Biosciences
• Intellia Therapeutics
• Shanghai BDgene Therapeutics Co
• SNIPR Biome

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN29082025004107003653ID1109992341